M2-S31N inhibitors (Fox Chase Chemical Diversity Center)

N/A

Report date: 2025/03/20 14:45:21
NME

Base Information

Drug NameM2-S31N inhibitors (Fox Chase Chemical Diversity Center)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix protein 2 inhibitorsMitochondrial ribosomal protein S31 inhibitors
TargetsMitochondrial ribosomal protein S31Matrix protein 2
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFox Chase Chemical Diversity Center Inc
China Registration ClassN/A

Develop Information

Active CompaniesFox Chase Chemical Diversity Center Inc
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A